BEIJING, Oct. 14 /PRNewswire-Asia-FirstCall/ -- Dehaier Medical Systems Ltd. (Nasdaq: DHRM) ("Dehaier" or the "Company"), an emerging leader in the development, assembly, marketing and sale of medical devices and homecare medical products in China, today announced that on October 12, 2010, Dehaier exhibited its entire product line at the China International Medical Equipment Fair ("CMEF") held in Shenyang.
CMEF is the largest exhibition of medical equipment and related products and services in the Asia-Pacific region and is held twice a year. The exhibition covers tens of thousands of products, such as medical imaging, in vitro diagnosis, electronics, optics, first aid, rehabilitation nursing, medical information technology, and outsourcing services to the entire medical industry. The Spring 2010 CMEF exhibition in Shenzhen attracted participants from over 2,000 medical equipment producers representing more than 20 countries, as well as more than 65,000 visitors including government purchasers, procurement specialists from hospitals, and distributors from more than 100 countries.
At its exhibition booth, Dehaier promoted its latest self-branded homecare products across eight different series, including CPAP devices, oxygen generators, and screening and diagnosis products. Dehaier also displayed various types of high-quality products for which it acts as a distributor, including products used in homecare, medical, and technical services.
Mr. Ping Chen, CEO of Dehaier, stated, "Attending CMEF, the largest gathering of medical equipment companies and professionals in the Asia-Pacific region, created an ideal platform to promote our brand image and an outstanding venue for cooperation and academic exchange. Dehaier entertained and negotiated with over 1,000 clients at our show desk during the first day of the exhibition. Out of all of our product portfolios, Personalized Homecare Products and our Customer Experience Center concept were the most popular. We believe the exhibition in Shenyang will emphasize our strategy in developing our medical business, which will create new opportunities for our company."
Mr. Chen continued, "We are very pleased to announce that during the first exhibition day, we received Initial Indication Letters for procurement agreements with over 10 distributors. Based on our historical results in moving from non-binding indications of interest into actual purchase orders, we expect that we may generate more than $1.2 million in sales from these distributors. Based on our strong financial performance so far this year, as well as the enthusiastic response we've had already at the exhibition, we look forward to continued growth in our business over the remainder of the year."
In the first six months of fiscal 2010, Dehaier generated $7.5 million in revenues, an increase of 28% from the first half of fiscal 2009. Sales for the second quarter ended June 30, 2010 were $4.8 million, up 46% from the previous year. Dehaier also generated $1.7 million in net income for the first six months of 2010, a 55% increase from the same period in 2009. Net income for the second quarter was $1.1 million, up 59% from the second quarter of 2009.
About Dehaier Medical Systems Ltd.
Dehaier Medical Systems is an emerging leader in the development, assembly, marketing and sale of medical products in China, including respiratory and oxygen homecare medical products. The company develops and assembles its own branded products from third-party components. The company also distributes products designed and manufactured by other companies, including medical devices and respiratory and oxygen homecare products from IMD (Italy), Welch Allyn (USA), Penlon (UK), HEYER (Germany), Timesco (UK), ResMed (Australia), and JMS (Japan). Dehaier's technology is based on two patents, five pending patents, and proprietary technology. More information may be found at http://www.chinadhr.com.
This news release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, changes in technology, economic conditions, the impact of competition and pricing, government regulation, and other risks contained in reports filed by the company with the Securities and Exchange Commission. All such forward-looking statements, whether written or oral, and whether made by or on behalf of the company, are expressly qualified by the cautionary statements and any other cautionary statements which may accompany the forward-looking statements. In addition, the company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.
SOURCE Dehaier Medical Systems Ltd.